ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
David H. Harpole, Jr
Michael J. Liptay
Malcolm M. DeCamp, Jr
Steven J. Mentzer
Scott J. Swanson
David J. Sugarbaker
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harpole, D. H.
Right arrow Articles by Sugarbaker, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harpole, D. H., Jr
Right arrow Articles by Sugarbaker, D. J.

Ann Thorac Surg 1996;61:977-982
© 1996 The Society of Thoracic Surgeons


Original Articles: General Thoracic

Prospective Analysis of Pneumonectomy: Risk Factors for Major Morbidity and Cardiac Dysrhythmias

David H. Harpole, Jr, MD, Michael J. Liptay, MD, Malcolm M. DeCamp, Jr, MD, Steven J. Mentzer, MD, Scott J. Swanson, MD, David J. Sugarbaker, MD

Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

Accepted for publication November 27, 1995.


    Abstract
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Background. Data were acquired prospectively on 136 consecutive patients undergoing pneumonectomy for cancer from 1988 to 1993, to define factors that increase the risk of major morbidity and postoperative cardiac dysrhythmias.

Methods. There were 81 patients (60%) with non--small cell lung cancer (standard pneumonectomy) and 55 patients (40%) with malignant pleural mesothelioma (extrapleural pneumonectomy).

Results. Four perioperative deaths occurred (3%) with no identifiable associated risk factors. Twenty-three patients (17%) had a major complication with an increase in the median length of stay from 7 to 11 days (p < 0.01). Age greater than 65 years, right-sided procedures, and dysrhythmias were associated with an increased risk of a major complication (p < 0.05). Thirty-two patients (24%) had supraventricular dysrhythmias, which occurred on postoperative days 1 to 2 (n = 8), 3 to 4 (n = 13), 5 to 6 (n = 6), and 7 to 12 (n = 5). The median length of stay increased from 8 to 11 days with dysrhythmias (p < 0.05). Factors associated with an increased risk of dysrhythmias (p < 0.05) included age greater than 65 years, intrapericardial or extrapleural pneumonectomy, right-sided procedure, and any major complication.

Conclusions. Pneumonectomy can be performed safely in selected patients with cancer. Supraventricular dysrhythmia was the most common complication noted with a peak incidence at 3 to 4 days after resection.


    Introduction
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
After the first report of a complete pneumonectomy for lung cancer by Evarts Graham of St. Louis in 1933, considerable interest arose in the use of pneumonectomy to treat lung cancer. In 1943, Bailey and Betts reported on complications after this operation and documented cardiac dysrhythmias in 9 of 78 patients [1, 2]. Since that time, many retrospective series of patients have been published that document supraventricular dysrhythmia as the most common complication after pulmonary resections [3--6]. Few of these reports analyzed for risk factors that were associated with major complications or cardiac dysrhythmias. In addition, few modern, prospectively collected data are available. Therefore, we prospectively collected data on a series of patients undergoing a pneumonectomy for cancer to document complications and to define the incidence, timing, and risk of postoperative cardiac dysrhythmias. Univariate analyses were undertaken to define risk factors that may influence the risk of complications and cardiac dysrhythmias after these major pulmonary resections.


    Material and Methods
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Population
Data were prospectively collected on 883 consecutive patients undergoing pulmonary resections for cancer from October 1, 1988, until September 30, 1993, at the Division of Thoracic Surgery of the Brigham and Women's Hospital. The procedures included 136 pneumonectomies, 361 lobectomies, and 386 segmental or wedge resections. All patients were admitted to the Thoracic Surgery Intermediate Care Unit after operation and were maintained on ambulatory electrocardiographic (ECG) telemetry for the duration of the hospitalization to accurately document any dysrhythmias. Continuous monitoring enabled precise, timely evaluation of both biochemical and physiologic parameters during the onset of supraventricular dysrhythmias. No pharmacologic prophylaxis was undertaken. No minimum length of stay was adopted. Patients were discharged when cardiopulmonary and nutritional status allowed.

This current study concentrated on the 136 patients (mean age, 56 ± 10 years; range, 27 to 74 years) who had undergone a pneumonectomy for non--small cell lung cancer (NSCLC; n = 81) or malignant pleural mesothelioma (n = 55).

Indications for pneumonectomy in NSCLC included central lesions invading the hilar structures, lesions that spanned the fissure (left side), or those involving both right upper and lower lobes. Although a bronchoplastic ``sleeve'' lobectomy was attempted in several patients, extensive involvement of the hilar structures required a pneumonectomy for an adequate tumor margin. (Twelve other patients underwent a successful ``sleeve'' resection during the study period.) Extrapleural pneumonectomy was performed in selected patients with malignant pleural mesothelioma if preoperative staging (documented by computed tomography and magnetic resonance imaging) revealed disease limited to the hemithorax in the absence of vital mediastinal structure invasion.

Exclusion criteria for pneumonectomy included age older than 75 years, poor Karnofsky performance status (<80), unstable cardiac disease (defined by an abnormal exercise test and echocardiogram), carbon dioxide tension greater than 50 mm Hg, resting pulse oximetry less than 90% or 6-minute exercise oximetry less than 88%, and a low body surface area--corrected, predicted postoperative forced expiratory volume in 1 second (FEV1). No patient who had undergone a previous contralateral pulmonary resection was considered for a pneumonectomy. However, a median sternotomy for prior coronary bypass procedures (n = 4) was not a contraindication.

Complete prospective data were recorded on these 136 study patients, including sex, age, presenting signs and symptoms, forced vital capacity, FEV1, rest and exercise pulse oximetry, room air arterial blood gas, and computed tomography of the head, chest, and abdomen. Predicted postoperative FEV1 was calculated as follows: For patients with preoperative FEV1 greater than 2.0 L, left pneumonectomy postoperative FEV1 = 0.55 x preoperative FEV1, and right pneumonectomy postoperative FEV1 = 0.45 x preoperative FEV1. For patients with preoperative FEV1 less than 2.0 L, a radionuclide ventilation/perfusion scan was obtained: postoperative FEV1 = (1 - % of ventilation in pneumonectomy) x preoperative FEV1.

A baseline cardiac assessment was performed, which included a cardiac history and physical examination and a 12-lead electrocardiogram. Data collected after admission to the hospital included the operative procedure, pathologic description, pathologic staging, any postoperative complications, the timing and type of dysrhythmia, and hospital length of stay. Serum potassium, magnesium, and calcium levels, hematocrit, blood pressure, and oxygen saturation were recorded at the onset of atrial dysrhythmia.

Operative Technique
Pneumonectomy for NSCLC was accomplished through a serratus-sparing posterolateral thoracotomy in the fifth intercostal space. Intrapericardial dissection was undertaken for an adequate vascular margin or for control of the ipsilateral main pulmonary artery if significant hilar scarring or adenopathy was evident. A pericardial fat pad was used to cover the stapled bronchial stump. Extrapleural pneumonectomy was accomplished through a full posterolateral thoracotomy with excision of the sixth rib. The tumor was resected en bloc with the lung, parietal pleura, diaphragm, and pericardium. A pericardial fat pad was used to cover the bronchial stump. The pericardium was reconstructed (right-sided tumors) with 0.1-mm Gore-Tex membrane (W. L. Gore & Assoc, Flagstaff, AZ), whereas the diaphragm was reconstructed with 2-mm Gore-Tex membrane [7].

Statistical Analysis
Analysis of variance was used to assess a difference in complications and dysrhythmias between the operative procedures. Fisher's exact test was used to assign significance of any association between any recorded variables and the presence of a major complication or cardiac dysrhythmia. A temporal relationship for postoperative dysrhythmias was assessed using the Pearson {chi}2 method. Because of the limited population size, subset analysis and multivariate analyses were not undertaken.


    Results
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
There were 81 patients who underwent a pneumonectomy for NSCLC, 46 (57%) of whom had an intrapericardial dissection. There were 55 patients with malignant pleural mesothelioma who underwent an extrapleural pneumonectomy.

Mortality
Data recorded after pneumonectomy revealed four perioperative deaths (3%). One patient died of a myocardial infarction on postoperative day 1. Postmortem examination revealed an occult 75% stenosis of the left main coronary artery and an acute anterior myocardial infarction. The remaining 3 patients died of sepsis and adult respiratory distress syndrome due to pneumonia from 14 to 30 days after operation. There were no other in-hospital deaths. Analysis revealed no identifiable factors associated with mortality.

Minor Complications
Thirty-three patients (24%) had minor complications, including atrial dysrhythmias, wound infections, bronchoscopy for secretions, contralateral pneumothorax, or a urinary tract infection (Table 1Go). Transient or permanent vocal cord paralysis was also included; however, 2 of the 5 patients with vocal cord paralysis required deliberate sacrifice of the recurrent nerve due to tumor involvement (see Table 1Go). The median hospital length of stay was significantly increased with a minor complication (7 to 9 days; p < 0.007).


View this table:
[in this window]
[in a new window]
 
Table 1. . Complications After Pneumonectomy (n = 136)a
 
Major Complications
Including the 4 patients who died, the major morbidity rate was 23 of 136 (17%). Major complications included reintubation, reoperation for bleeding or infection, pneumonia or empyema, pulmonary edema or adult respiratory distress syndrome, and myocardial infarction. The median length of stay was increased from 7 to 11 days with the presence of a major complication (p < 0.004). For comparison, during the same time interval at our institution, there were five deaths (1.4%) and 34 major complications (9%) among 361 patients who received a lobectomy for cancer.

Univariate analysis was undertaken to define factors that might be associated with major complications. No association was found for any forced vital capacity range, FEV1 measurement (2.27 ± 0.60 L; range, 1.1 to 4.0 L), predicted postoperative FEV1 estimates (1.15 ± 0.29 L; range, 0.72 to 2.0 L), carbon dioxide tension (range, 30 to 54 mm Hg), oxygen tension (range, 62 to 102 mm Hg) or creatinine levels (Table 2Go). All patients with a marginal predicted postoperative FEV1 and a good performance status underwent exercise testing to verify adequate oxygen consumption with exercise. There were 5 patients with a predicted postoperative FEV1 less than 0.8 L (1 man, 0.76 L; 4 women, 0.72 to 0.77 L). These patients were small (body surface area--corrected values were in the normal range), and there was no increased rate of complications or dysrhythmias in this subset of patients. The type of resection (extrapleural for mesothelioma or standard pneumonectomy for NSCLC), intrapericardial dissection for NSCLC, the status of lymph node involvement, or the presence of a nondysrhythmic minor complication did not increase the risk of a major complication. However, age greater than 65 years, right-sided procedures, and the presence of a dysrhythmia were associated with major complications (see Table 2Go).


View this table:
[in this window]
[in a new window]
 
Table 2. . Risk Factors of Major Complications
 
Dysrhythmias
To define the incidence, timing, and risk of postoperative cardiac dysrhythmias, we analyzed ECG data from all patients who had undergone a pulmonary resection for lung cancer during the study period. There were 81 cases of supraventricular dysrhythmia in the postoperative period among the total population of 883 patients (9%). The rate of postoperative supraventricular dysrhythmias was 5/386 (1%) for wedge or segmental resection, 44/361 (12%) for lobectomy, and 32/136 (24%) for pneumonectomy (p < 0.001). Sustained ventricular ectopy was uncommon in all groups (<1%). The remaining analysis were conducted on the 136 pneumonectomy patients who demonstrated a 24% incidence of supraventricular dysrhythmias. No pneumonectomy patient had a history of dysrhythmias or was receiving antiarrhythmic medication before operation.

Biochemical and physiologic parameters analyzed during the onset of atrial arrhythmias included blood pressure, oxygen saturation, serum potassium, magnesium, and calcium levels, and hematocrit (Table 3Go). No single biochemical or physiologic variable was significantly associated with the occurrence of atrial dysrhythmias after pneumonectomy. The parameters studied suggest a multifactorial basis for the onset of dysrhythmia in these patients. Thirty-two patients (24%) had supraventricular dysrhythmias, which occurred on postoperative days 1 to 2 (n = 8), 3 to 4 (n = 13), 5 to 6 (n = 6), and 7 to 12 (n = 5) (Fig 1Go). Treatment consisted of rate control with digoxin (n = 28) and electrical cardioversion (150 to 200 joules) after digoxin (n = 4). All digoxin patients were also treated with procainamide or diltiazem after rate control had been achieved. ß-Blockers were not used in this group of patients with impaired pulmonary status. Administration of antiarrhythmic medications was discontinued at 6 weeks after operation. Length of stay was significantly increased from a median of 8 to 11 days with the presence of supraventricular dysrhythmias (p < 0.05). All measured variables were tested for an association with dysrhythmias (Tables 4, 5GoGo). No risk groups could be defined by preoperative spirometry or predicted postoperative pulmonary function, preoperative arterial blood gas measurements, or creatinine level. A significantly increased incidence of dysrhythmias was observed for age greater than 65 years, extrapleural or intrapericardial pneumonectomy, and right-sided procedures. A significant association was observed for the presence of a major complication and supraventricular dysrhythmia.


View this table:
[in this window]
[in a new window]
 
Table 3. . Biochemical and Physiologic Variables at Onset of Atrial Dysrhythmia
 


View larger version (11K):
[in this window]
[in a new window]
 
Fig 1. . Timing of the appearance of the supraventricular dysrhythmia is shown (n = 32). A significant temporal relationship was observed (p < 0.05).

 

View this table:
[in this window]
[in a new window]
 
Table 4. . Length of Stay and Dysrhythmias After Operation
 

View this table:
[in this window]
[in a new window]
 
Table 5. . Risk Factors of Dysrhythmias
 

    Comment
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
The goal of thoracic surgical oncology is the extirpation of malignancy with preservation of the functional status of the patient. Pneumonectomy was initially performed in all patients with localized NSCLC. However, it became apparent that a curative resection could be obtained with lobectomy in many cases, thereby preserving more lung tissue. Pneumonectomy remains useful for patients whose tumor is centrally located, invades across fissures and involves both lobes on the left, or involves the upper and lower lobes on the right. Another contemporary application of pneumonectomy is in the multidisciplinary management of selected patients with malignant pleural mesothelioma. If the tumor is confined within the parietal pleura of one hemithorax, it can be resected en bloc with an extrapleural pneumonectomy. This operation provides maximal cytoreduction and survival benefit in the well-selected patient [8].

Because most of the data regarding pneumonectomy in the literature are older and retrospective, the goals of this study were to use a contemporary cohort of cancer patients to define prospectively factors that might have an impact on perioperative mortality, major complications, or cardiac dysrhythmias after pneumonectomy.

The risk of mortality and morbidity is greater for pneumonectomy compared with smaller pulmonary resections. A multicenter, prospective series of 569 pneumonectomies from the Lung Cancer Study Group observed a perioperative mortality rate of 6.2% [9]. However, in the modern era of accurate preoperative assessment, pulmonary rehabilitation, thoracic anesthesia, and careful postoperative management, the 30-day mortality rate would be expected to decline. Our 3% operative mortality obtained over a 5-year period supports this expectation and is favorable when compared with most series published in the literature over the last five decades (Table 6Go) [1, 3--6, 10--18]. The major morbidity rate in our series of 136 patients was 17% and did not affect overall survival. This rate of complications after pneumonectomy is comparable with the major morbidity rates of 12% to 36% published in the literature [12, 16, 17, 19, 20].


View this table:
[in this window]
[in a new window]
 
Table 6. . Literature Review of Retrospective Pneumonectomy Series With More Than 75 Patients
 
A second goal of this project was to examine individual factors that might be associated with morbidity, especially cardiac dysrhythmias. A recent prospective evaluation of morbidity after major pulmonary resection for cancer was reported by Kearney and colleagues [19]. That group collected data on 331 patients, including 46 who underwent a pneumonectomy. Univariate predictors of increased risk for major complications included age greater than 60 years, male sex, pneumonectomy, and predicted postoperative FEV1. Only calculated postoperative FEV1 was a significant independent factor for major morbidity [19]. In the current study, all 136 pneumonectomy patients had preoperative spirometry, but no values could be found that significantly affected the rate of any complications, including dysrhythmias. A predicted postoperative FEV1 less than 1.0 L for men and less than 0.8 L for women failed to predict an adverse event in our population. This may be attributed to the small study size and could be clarified by a large, prospective, multicenter study of pneumonectomy patients.

Several other studies that compared the rate of complications and dysrhythmias in patients who had undergone lobectomy or pneumonectomy have shown an increased rate of major complications and dysrhythmias after pneumonectomy as compared with lobectomy, cancer resections compared with operations for a benign disease, and larger resections (extrapleural pneumonectomy) compared with standard pneumonectomy [12, 13, 15, 17, 19, 20]. Patient data collected at our institution during this 5-year study found a significantly higher rate of morbidity and mortality for the 136 pneumonectomy patients compared with 361 lobectomy patients. Because all analyses were performed on patients with resections for cancer, no comparisons were made with resections for benign disease. Extrapleural pneumonectomy has been viewed by some as a procedure associated with a prohibitive mortality and morbidity. In the present series, the mortality and morbidity rates for extrapleural pneumonectomy were 4% and 16%, whereas mortality and morbidity rates for standard pneumonectomy were 2% and 24% (p = not significant), signifying that an extrapleural pneumonectomy can be performed with reasonable safety in appropriately selected patients.

A prior history of significant cardiac disease has been previously associated with postoperative complications and atrial dysrhythmias (see Table 6Go) [1, 3--6, 10--18]. Although 4 of our 136 patients had undergone a previous coronary bypass procedure and several others had stable angina (proven with an adequate ECG stress test), no historical factor could be associated with major morbidity or dysrhythmias. However, we did observe an increased rate of complications and dysrhythmias for patients more than 65 years of age (see Tables 2, 5GoGo). Similar to previous reports, an increased rate of dysrhythmias was observed for the patients with an extrapleural or intrapericardial pneumonectomy and those who had a right-sided procedure. Both the resection of pericardium and resection of the right lung, which is in proximity to the sinoatrial node, can cause postoperative atrial irritation. The rate of intrapericardial dissection for the patients with NSCLC was 46 of 81 (57%). This is attributed to the high rate of neoadjuvant therapy given to patients in the intrapericardial group (32 of 46; 70%).

No association was observed between atrial dysrhythmias and mortality for our study of 136 patients. However, several authors have noted a significant mortality (up to 30%) for patients who had sustained or recurrent dysrhythmias, emphasizing the importance of early diagnosis and treatment [13, 17].

In our study, continuous ambulatory ECG monitoring was used to make sure that no rhythm disturbances were missed. This may explain the 24% rate observed in this population, which is slightly higher than the rate quoted from retrospective series in the literature (see Table 6Go) [1, 3--6, 10--18]. However, the incidence of ventricular ectopy was very low (1 of 136 pneumonectomy patients; <1%). Continuous monitoring documented the timing of the dysrhythmias. We observed a peak incidence at 3 to 4 days after operation (see Fig 1Go), confirming a need for ambulatory ECG telemetry during hospitalization and counseling against early discharge of the pneumonectomy patient. Continuous ECG monitoring also allowed prospective documentation of physiologic or biochemical parameters at the onset of the arrhythmia. Results demonstrated that no single factor was associated with atrial dysrhythmias (see Table 3Go). A larger patient population would allow subset analyses, which can define factors that covary with dysrhythmias. Importantly, only 2 patients were discharged in atrial fibrillation, and no patient was in atrial fibrillation at 6 weeks. We do not anticoagulate patients and usually discontinue administration of antiarrhythmic medications 6 to 8 weeks after operation, provided the patient has been maintained in sinus rhythm.

In summary, pneumonectomy can be performed with acceptable risk for selected patients with localized NSCLC and malignant pleural mesothelioma. Factors associated with an increased risk of major morbidity were age greater than 65 years and the presence of supraventricular dysrhythmias. Supraventricular dysrhythmias are the most common complication of pneumonectomy (24%), with a peak incidence 1 to 5 days after resection, suggesting the need for ambulatory telemetry ECG monitoring after operation. Factors that were associated with a greater risk of supraventricular dysrhythmias were age greater than 65 years, intrapericardial or extrapleural pneumonectomy, right-sided procedures, and the presence of any other postoperative complication. No single physiologic or biochemical factor was associated with the onset of dysrhythmias, signifying a multifactorial etiology.

Although the rate of major complications and supraventricular dysrhythmias is acceptable, the length of stay was significantly increased with their presence. The present population of patients can act as a model for a multicenter analysis. The results from such a study should aid in defining risk factors that have a significant association with major complications and dysrhythmias, thereby identifying subgroups of patients appropriate for prophylactic interventions before a planned pneumonectomy.


    Acknowledgments
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
We acknowledge James E. Herndon, PhD, of the Cancer and Leukemia Group B Statistical Office at Duke University Medical Center for completing the statistical analyses for this report and Mary Sullivan Visciano for editorial assistance.


    Footnotes
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Address reprint requests to Dr Harpole, Division of Thoracic Surgery, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115.


    References
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 

  1. Bailey CC, Betts RH. Cardiac arrhythmias following pneumonectomy. N Engl J Med 1943;229:356–9.
  2. Currens JH, White PD, Churchill ED. Cardiac arrhythmias following thoracic surgery. N Engl J Med 1943;229:360–4.
  3. Massie E, Valle AR. Cardiac arrhythmias complicating total pneumonectomy. Ann Intern Med 1947;26:231–9.[Abstract/Free Full Text]
  4. Hurt RL, Bates M. The value of quinidine in the prevention of cardiac arrhythmias after pulmonary resection. Thorax 1958;13:39–41.[Medline]
  5. Wheat MW Jr, Burford TH. Digitalis in surgery: extension of classical indications. J Thorac Cardiovasc Surg 1961;41:162–8.[Medline]
  6. Bergh NP, Dottori O, Malmberg R. Prophylactic digitalis in thoracic surgery. Scand J Respir Dis 1967;48:197–200.
  7. Sugarbaker DJ, Mentzer SJ, Strauss G. Extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma. Ann Thorac Surg 1992;53:165–6.[Abstract]
  8. Sugarbaker DJ, Strauss GM, Lynch TJ. Node status has prognostic significance in multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol 1993;11:1172–8.[Abstract/Free Full Text]
  9. Ginsberg RJ, Hill LD, Eagan RT. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 1983;99:218–26.
  10. Stougard J. Cardiac arrhythmias following pneumonectomy. Thorax 1969;24:568–72.[Abstract/Free Full Text]
  11. Harmon H, Fergus S, Cole FH. Pneumonectomy: review of 351 cases. Ann Surg 1976;183:719–22.[Medline]
  12. Keagy BA, Schorlemmer GR, Murray GF, Starek PJ, Wilcox BR. Correlation of preoperative pulmonary function testing with clinical course in patients after pneumonectomy. Ann Thorac Surg 1983;36:253–7.[Abstract]
  13. Krowka MJ, Pairolero PC, Trastek VF, Payne WS, Bernatz PE. Cardiac dysrhythmia following pneumonectomy. Clinical correlates and prognostic significance. Chest 1987;91:490–5.[Abstract/Free Full Text]
  14. Yellin A, Zeligson E. Postpneumonectomy dysrhythmias. Chest 1988;93:669.[Medline]
  15. Zukerman C, Hubsch JP, Dumouchel A, Debesse B. Cardiac rhythm disorders after pneumonectomy. Rev Pneumol Clin 1985;41:115–9.[Medline]
  16. Deslauriers J, Ginsberg RJ, Dubois P, Beaulieu M, Goldberg M, Piraux M. Current operative morbidity associated with elective surgical resection for lung cancer. Can J Surg 1989;32:335–9.[Medline]
  17. Wahi R, McMurtrey MJ, DeCaro LF, et al. Determinants of perioperative morbidity and mortality after pneumonectomy. Ann Thorac Surg 1989;48:33–7.[Abstract]
  18. Von Knorring J, Lepantalo M, Lindgren L, Lindfors O. Cardiac arrhythmias and myocardial ischemia after thoracotomy for lung cancer. Ann Thorac Surg 1992;53:642–7.[Abstract]
  19. Kearney DJ, Lee TH, Reilly JJ, DeCamp MM, Sugarbaker DJ. Assessment of operative risk in patients undergoing lung resection: importance of predicted pulmonary function. Chest 1994;104:753–8.
  20. Nagasaki F, Flehinger BJ, Martini N. Complications of surgery in the treatment of carcinoma of the lung. Chest 1982;82:25–9.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
J. E. Tisdale, H. A. Wroblewski, D. S. Wall, K. M. Rieger, Z. T. Hammoud, J. V. Young, and K. A. Kesler
A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection.
Ann. Thorac. Surg., September 1, 2009; 88(3): 886 - 893.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
S. Limmer, L. Hauenschild, C. Eckmann, R. Czymek, H. Schmidt, H.-P. Bruch, and P. Kujath
Thoracic surgery in the elderly - co-morbidity is the limit
Interactive CardioVascular and Thoracic Surgery, April 1, 2009; 8(4): 412 - 416.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
S. Neragi-Miandoab, S. Weiner, and D. J. Sugarbaker
Incidence of atrial fibrillation after extrapleural pneumonectomy vs. pleurectomy in patients with malignant pleural mesothelioma
Interactive CardioVascular and Thoracic Surgery, December 1, 2008; 7(6): 1039 - 1042.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Gudbjartsson, E. Gyllstedt, A. Pikwer, and P. Jonsson
Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy
Ann. Thorac. Surg., August 1, 2008; 86(2): 376 - 382.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
L. Luzzi, S. Tenconi, L. Voltolini, P. Paladini, C. Ghiribelli, M. Di Bisceglie, and G. Gotti
Long-term respiratory functional results after pneumonectomy.
Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 164 - 168.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. L. Colice, S. Shafazand, J. P. Griffin, R. Keenan, and C. T. Bolliger
Physiologic Evaluation of the Patient With Lung Cancer Being Considered for Resectional Surgery: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 161S - 177S.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Weinstein, A. T. Bates, B. E. Spaltro, H. T. Thaler, and R. M. Steingart
Influence of Preoperative Exercise Capacity on Length of Stay After Thoracic Cancer Surgery
Ann. Thorac. Surg., July 1, 2007; 84(1): 197 - 202.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
A. Shaw
Genetics of postoperative complications following thoracic surgery.
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 327 - 345.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
S.-W. Song, H.-S. Lee, M. S. Kim, J. M. Lee, J. H. Kim, B.-H. Nam, and J. I. Zo
Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection
Ann. Thorac. Surg., June 1, 2006; 81(6): 1974 - 1981.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
O. Schussler, M. Alifano, H. Dermine, S. Strano, A. Casetta, S. Sepulveda, A. Chafik, S. Coignard, A. Rabbat, and J.-F. Regnard
Postoperative Pneumonia after Major Lung Resection
Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1161 - 1169.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
I. Opitz, P. Kestenholz, D. Lardinois, M. Muller, V. Rousson, D. Schneiter, R. Stahel, and W. Weder
Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma.
Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 579 - 584.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. Doddoli, F. Barlesi, D. Trousse, S. Robitail, S. Yena, P. Astoul, R. Giudicelli, P. Fuentes, and P. Thomas
One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: An uncertain balance between risks and benefits
J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 416 - 425.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. E. Roselli, S. C. Murthy, T. W. Rice, P. L. Houghtaling, C. D. Pierce, D. P. Karchmer, and E. H. Blackstone
Atrial fibrillation complicating lung cancer resection
J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 438 - 444.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
D. J. Stewart, A. E. Martin-Ucar, J. G. Edwards, K. West, and D. A. Waller
Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations
Eur. J. Cardiothorac. Surg., March 1, 2005; 27(3): 373 - 378.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
G. J. Schaffler, G. Wolf, H. Schoellnast, R. Groell, A. Maier, F. M. Smolle-Juttner, M. Woltsche, G. Fasching, R. Nicoletti, and R. M. Aigner
Non-Small Cell Lung Cancer: Evaluation of Pleural Abnormalities on CT Scans with 18F FDG PET
Radiology, June 1, 2004; 231(3): 858 - 865.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. A. Vaporciyan, A. M. Correa, D. C. Rice, J. A. Roth, W. R. Smythe, S. G. Swisher, G. L. Walsh, and J. B. Putnam Jr
Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients
J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 779 - 786.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
A. Stolz, J. Schutzner, J. Simonek, R. Lischke, and P. Pafko
Comparison of postoperative complications of 60- and 70-year-old patients after lung surgery
Interactive CardioVascular and Thoracic Surgery, December 1, 2003; 2(4): 620 - 623.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
V. Ambrogi, E. Pompeo, S. Elia, G. R. Pistolese, and T. C. Mineo
The impact of cardiovascular comorbidity on the outcome of surgery for stage I and II non-small-cell lung cancer
Eur. J. Cardiothorac. Surg., May 1, 2003; 23(5): 811 - 817.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. A. Fuentes
Pneumonectomy: historical perspective and prospective insight
Eur. J. Cardiothorac. Surg., April 1, 2003; 23(4): 439 - 445.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
C. N. Foroulis, C. Kotoulas, H. Lachanas, G. Lazopoulos, M. Konstantinou, and A. G. Lioulias
Factors associated with cardiac rhythm disturbances in the early post-pneumonectomy period: a study on 259 pneumonectomies
Eur. J. Cardiothorac. Surg., March 1, 2003; 23(3): 384 - 389.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
F. J. Algar, A. Alvarez, A. Salvatierra, C. Baamonde, J. L. Aranda, and F. J. Lopez-Pujol
Predicting pulmonary complications after pneumonectomy for lung cancer
Eur. J. Cardiothorac. Surg., February 1, 2003; 23(2): 201 - 208.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. van Ruth, P. Baas, and F. A. N. Zoetmulder
Surgical Treatment of Malignant Pleural Mesothelioma: A Review
Chest, February 1, 2003; 123(2): 551 - 561.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. A. Lanza, A. I. Visbal, P. A. DeValeria, A. R. Zinsmeister, N. N. Diehl, and V. F. Trastek
Low-dose oral amiodarone prophylaxis reduces atrial fibrillation after pulmonary resection
Ann. Thorac. Surg., January 1, 2003; 75(1): 223 - 230.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. A. Beckles, S. G. Spiro, G. L. Colice, and R. M. Rudd
The Physiologic Evaluation of Patients With Lung Cancer Being Considered for Resectional Surgery
Chest, January 1, 2003; 123 (2009): 105S - 114S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Licker, A. Spiliopoulos, J.-G. Frey, J. Robert, L. Hohn, M. de Perrot, and J.-M. Tschopp
Risk Factors for Early Mortality and Major Complications Following Pneumonectomy for Non-small Cell Carcinoma of the Lung*
Chest, June 1, 2002; 121(6): 1890 - 1897.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Brunelli, M. Al Refai, M. Monteverde, A. Borri, M. Salati, and A. Fianchini
Stair Climbing Test Predicts Cardiopulmonary Complications After Lung Resection*
Chest, April 1, 2002; 121(4): 1106 - 1110.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. A. Vaporciyan, K. W. Merriman, F. Ece, J. A. Roth, W. R. Smythe, S. G. Swisher, G. L. Walsh, J. C. Nesbitt, and J. B. Putnam Jr
Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation
Ann. Thorac. Surg., February 1, 2002; 73(2): 420 - 426.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
Y. Sekine, K. A. Kesler, M. Behnia, J. Brooks-Brunn, E. Sekine, and J. W. Brown
COPD May Increase the Incidence of Refractory Supraventricular Arrhythmias Following Pulmonary Resection for Non-small Cell Lung Cancer
Chest, December 1, 2001; 120(6): 1783 - 1790.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
O. Rena, E. Papalia, A. Oliaro, C. Casadio, E. Ruffini, P. Filosso, C. Sacerdote, and G. Maggi
Supraventricular arrhythmias after resection surgery of the lung
Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 688 - 693.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Myrdal, G. Gustafsson, M. Lambe, L.G. Horte, and E. Stahle
Outcome after lung cancer surgery. Factors predicting early mortality and major morbidity
Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 694 - 699.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Martin, R. J. Ginsberg, A. Abolhoda, M. S. Bains, R. J. Downey, R. J. Korst, T. L. Weigel, M. G. Kris, E. S. Venkatraman, and V. W. Rusch
Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy
Ann. Thorac. Surg., October 1, 2001; 72(4): 1149 - 1154.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
I. AURIANT, A. JALLOT, P. HERVE, J. CERRINA, F. LE ROY LADURIE, J. L. FOURNIER, B. LESCOT, and F. PARQUIN
Noninvasive Ventilation Reduces Mortality in Acute Respiratory Failure following Lung Resection
Am. J. Respir. Crit. Care Med., October 1, 2001; 164(7): 1231 - 1235.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. Deschamps, A. Bernard, F. C. Nichols III, M. S. Allen, D. L. Miller, V. F. Trastek, G. D. Jenkins, and P. C. Pairolero
Empyema and bronchopleural fistula after pneumonectomy: factors affecting incidence
Ann. Thorac. Surg., July 1, 2001; 72(1): 243 - 248.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Bernard, C. Deschamps, M. S. Allen, D. L. Miller, V. F. Trastek, G. D. Jenkins, and P. C. Pairolero
Pneumonectomy for malignant disease: Factors affecting early morbidity and mortality
J. Thorac. Cardiovasc. Surg., June 1, 2001; 121(6): 1076 - 1082.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
F. Stephan, S. Boucheseiche, J. Hollande, A. Flahault, A. Cheffi, B. Bazelly, and F. Bonnet
Pulmonary Complications Following Lung Resection : A Comprehensive Analysis of Incidence and Possible Risk Factors
Chest, November 1, 2000; 118(5): 1263 - 1270.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Bernard, L. Ferrand, O. Hagry, L. Benoit, N. Cheynel, and J.-P. Favre
Identification of prognostic factors determining risk groups for lung resection
Ann. Thorac. Surg., October 1, 2000; 70(4): 1161 - 1167.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. W. Asaph, J. R. Handy Jr, G. L. Grunkemeier, E. C. Douville, A. C. Tsen, R. C. Rogers, and J. F. Keppel
Median sternotomy versus thoracotomy to resect primary lung cancer: analysis of 815 cases
Ann. Thorac. Surg., August 1, 2000; 70(2): 373 - 379.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. Ciriaco, P. Mazzone, B. Canneto, and P. Zannini
Supraventricular arrhythmia following lung resection for non-small cell lung cancer and its treatment with amiodarone
Eur. J. Cardiothorac. Surg., July 1, 2000; 18(1): 12 - 16.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. A. Kutlu, E. A. Williams, T. W. Evans, U. Pastorino, and P. Goldstraw
Acute lung injury and acute respiratory distress syndrome after pulmonary resection
Ann. Thorac. Surg., February 1, 2000; 69(2): 376 - 380.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. Cardinale, A. Martinoni, C. M. Cipolla, M. Civelli, G. Lamantia, C. Fiorentini, and M. Mezzetti
Atrial fibrillation after operation for lung cancer: clinical and prognostic significance
Ann. Thorac. Surg., November 1, 1999; 68(5): 1827 - 1831.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. H. Sterman, L. R. Kaiser, and S. M. Albelda
Advances in the Treatment of Malignant Pleural Mesothelioma
Chest, August 1, 1999; 116(2): 504 - 520.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. J. Curtis, B. M. Parker, C. A. McKenney, C. C. Wagner-Mann, J. T. Walls, T. L. Demmy, and R. A. Schmaltz
Incidence and predictors of supraventricular dysrhythmias after pulmonary resection
Ann. Thorac. Surg., November 1, 1998; 66(5): 1766 - 1771.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. A. Melendez and R. Barrera
Predictive respiratory complication quotient predicts pulmonary complications in thoracic surgical patients
Ann. Thorac. Surg., July 1, 1998; 66(1): 220 - 224.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Halezeroglu, M. Keles, A. Uysal, M. Celik, C. Senol, G. Haciibrahimoglu, and B. Arman
Factors Affecting Postoperative Morbidity and Mortality in Destroyed Lung
Ann. Thorac. Surg., December 1, 1997; 64(6): 1635 - 1638.
[Abstract] [Full Text]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
D. Amar
Postoperative Cardiac Arrhythmias: Prevention and Management
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1997; 1(3): 256 - 263.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. Amar, N. Roistacher, M. E. Burt, V. W. Rusch, M. S. Bains, D. H. Y. Leung, R. J. Downey, and R. J. Ginsberg
Effects of Diltiazem Versus Digoxin on Dysrhythmias and Cardiac Function After Pneumonectomy
Ann. Thorac. Surg., May 1, 1997; 63(5): 1374 - 1381.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
D. B. Campbell
Malignant Mesothelioma
Ann. Thorac. Surg., May 1, 1997; 63(5): 1503 - 1505.
[Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
David H. Harpole, Jr
Michael J. Liptay
Malcolm M. DeCamp, Jr
Steven J. Mentzer
Scott J. Swanson
David J. Sugarbaker
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harpole, D. H.
Right arrow Articles by Sugarbaker, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harpole, D. H., Jr
Right arrow Articles by Sugarbaker, D. J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS